Índice

• • ·Pancreatic cancer: cause for optimism?

    Página :845

     
• • ·Immunotherapy for small-cell lung cancer

    Página :846-847

    Yangqiu Li, Yi-long Wu

     
• • ·Age at cancer diagnosis and interpretation of survival statistics

    Página :847-848

    Philippe Autier

     
• • ·Lung cancer risk in new pulmonary nodules: implications for CT screening and nodule management

    Página :849-850

    David R Baldwin, Anand Devaraj

     
• • ·New options in treatment of advanced renal cancer

    Página :850-852

    Axel Bex

     
• • ·Choosing frontline chemoimmunotherapy for CLL

    Página :852-854

    Adrian Wiestner

     
• • ·Sequential immunotherapy regimens—expect the unexpected

    Página :854-855

    Patricio Serra-Bellver, Sara Valpione, Paul Lorigan

     
• • ·The promise of immunostimulatory antibodies in head and neck cancer

    Página :856-857

    Jean-Pascal H Machiels, Pierre G Coulie

     
• • ·Defining the role of radiotherapy for retroperitoneal sarcoma

    Página :857-859

    Elizabeth H Baldini

     
• • ·Trends in immunotherapy for brain metastases

    Página :859-860

    Rafael Rosell, Niki Karachaliou

     
• • ·Combined BRAF and MEK inhibition in BRAF-mutant NSCLC

    Página :860-862

    Gareth Rivalland, Paul Mitchell

     
• • ·Improved quality of life is the way to longer life

    Página :862-863

    Giuseppe Procopio, Raffaele Ratta, Filippo de Braud

     
• • ·SPAG5: the ultimate marker of proliferation in early breast cancer?

    Página :863-865

    François Bertucci, Patrice Viens, Daniel Birnbaum

     
• • ·Refugee children with cancer in Turkey

    Página :865-867

    Rejin Kebudi, Ibrahim Bayram, Begul Yagci-Kupeli, Serhan Kupeli, Gulay Sezgin, Esra Pekpak, Yesim Oymak, Dilek Ince, Suna Emir, Deniz Tugcu, Gulcihan Ozek, Ali Bay, Funda Tayfun Kupesiz, Sema Vural, Suheyla Ocak, Yontem Yaman, Yavuz Koksal, Cetin Timur, Selma Unal, Canan Vergin

    
• • ·Outcomes for girls without HPV vaccination in Japan

    Página :868-869

    Yusuke Tanaka, Yutaka Ueda, Tomomi Egawa-Takata, Asami Yagi, Kiyoshi Yoshino, Tadashi Kimura

     
• • ·Phosphenes in patients receiving radiotherapy

    Página :869-871

    Juliette Thariat, Cecilia Leal, Alessander d’Ascoli, Pauline Jardel, Jean Pierre Caujolle, Joel Herault, Stephanie Baillif, Celia Maschi, Giorgia Loreti

     
• • ·Adverse event development in clinical oncology trials

    Página :e263

    Iris Walraven, Neil Aaronson, Jan-Jakob Sonke, Marcel Verheij, José Belderbos

    
• • ·Adverse event development in clinical oncology trials

    Página :e263

    Claudia Schmoor, Ralf Bender, Jan Beyersmann, Meinhard Kieser, Martin Schumacher

    
• • ·Adverse event development in clinical oncology trials – Authors’ reply

    Página :e264

    Gita Thanarajasingam, Jeff A Sloan, Axel Grothey

    
• • ·The direct-to-consumer genetics debate

    Página :e265

    Andy Kill

    
• • ·LUX-Lung 7: is there enough data for a final conclusion?

    Página :e266

    Massimo Di Maio, Alfredo Addeo

    
• • ·LUX-Lung 7: is there enough data for a final conclusion?

    Página :e266

    Chunhong Hu, Haixia Zhang, Yang Zhang, Fang Wu, Jin-an Ma

    
• • ·LUX-Lung 7: is there enough data for a final conclusion?

    Página :e267

    Armando Orlandi, Maria Alessandra Calegari, Carlo Barone

    
• • ·LUX-Lung 7: is there enough data for a final conclusion? – Author’s reply

    Página :e268

    Keunchil Park

    
• • ·Correction to Lancet Oncol 2014; 16: 767

    Página :e270

    
• • ·Correction to Lancet Oncol 2015; 16: 1479

    Página :e270

    
• • ·Correction to Lancet Oncol 2016; 17: 351

    Página :e270

    
• • ·Correction to Lancet Oncol 2016; 17: 431, 434, 435

    Página :e270

    
• • ·Correction to Lancet Oncol 2016; 17: 888, 890, 892

    Página :e270

    
• • ·Correction to Lancet Oncol 2016; 17: 953

    Página :e270

    
• • ·Correction to Lancet Oncol 2016; 17: 995, 1002

    Página :e270

    
• • ·Cabazitaxel for metastatic hormone-relapsed prostate cancer treated with docetaxel

    Página :872-873

    Rosemary Lovett, Victoria Kelly, Melinda Goodall, Amanda I Adler

     
• • ·Digestive Disease Week 2016

    Página :874

    Rob Brierley

    Esquema Esquema  
• • ·2016 ASCO Annual Meeting

    Página :875-876

    Isabel Lokody

    Esquema Esquema  
• • ·Carcinogenicity of drinking coffee, mate, and very hot beverages

    Página :877-878

    Dana Loomis, Kathryn Z Guyton, Yann Grosse, Béatrice Lauby-Secretan, Fatiha El Ghissassi, Véronique Bouvard, Lamia Benbrahim-Tallaa, Neela Guha, Heidi Mattock, Kurt Straif, International Agency for Research on Cancer Monograph Working Group

     
• • ·Capecitabine and lapatinib treatment in head and neck cancer

    Página :e271

    Vicki Brower

     
• • ·National Health Service England introduces dose banding

    Página :e271

    Susan Mayor

    
• • ·Paediatric lymphocyte-predominant Hodgkin’s lymphoma

    Página :e272

    Talha Khan Burki

     
• • ·Cancer data in India show new patterns

    Página :e272

    Dinesh C Sharma

    
• • ·Good outcomes for lymphoma treatment during pregnancy

    Página :e273

    Vicki Brower

     
• • ·Stronger correlation of surrogate endpoints with survival needed

    Página :e273

    Robert H Carlson

    
• • ·Long waiting times for test results for NHS patients

    Página :e274

    Talha Khan Burki

     
• • ·Physical frailty in survivors of haemopoietic cell transplant

    Página :e274

    Vicki Brower

    
• • ·Extending aromatase inhibitor adjuvant therapy to 10 years

    Página :e275

    Holly Baker

     
• • ·Anti-PD-L1 inhibitor durvalumab in bladder cancer

    Página :e275

    Vicki Brower

    
• • ·New therapy for acute lymphoblastic leukaemia

    Página :e276

    Emma Wilkinson

     
• • ·Garlic: a stake through the heart of cancer?

    Página :879-880

    Alex de Giorgio, Justin Stebbing

      
• • ·Cancer awareness to live happily ever after

    Página :880-881

    Emilia Harding

     
• • ·One way: a journey to this moment

    Página :881

    Talha Khan Burki

     
• • ·Playing Where’s Wally with cancer

    Página :882

    Victoria Denny

     
• • ·Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

    Página :883-895

    Scott J Antonia, José A López-Martin, Johanna Bendell, Patrick A Ott, Matthew Taylor, Joseph Paul Eder, Dirk Jäger, M Catherine Pietanza, Dung T Le, Filippo de Braud, Michael A Morse, Paolo A Ascierto, Leora Horn, Asim Amin, Rathi N Pillai, Jeffry Evans, Ian Chau, Petri Bono, Akin Atmaca, Padmanee Sharma, Christopher T Harbison, Chen-Sheng Lin, Olaf Christensen, Emiliano Calvo

    Resumen Resumen Esquema Esquema   
• • ·Survival of European adolescents and young adults diagnosed with cancer in 2000–07: population-based data from EUROCARE-5

    Página :896-906

    Annalisa Trama, Laura Botta, Roberto Foschi, Andrea Ferrari, Charles Stiller, Emmanuel Desandes, Milena Maria Maule, Franco Merletti, Gemma Gatta, EUROCARE-5 Working Group †

    Resumen Resumen Esquema Esquema   
• • ·Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial

    Página :907-916

    Joan E Walter, Marjolein A Heuvelmans, Pim A de Jong, Rozemarijn Vliegenthart, Peter M A van Ooijen, Robin B Peters, Kevin ten Haaf, Uraujh Yousaf-Khan, Carlijn M van der Aalst, Geertruida H de Bock, Willem Mali, Harry J M Groen, Harry J de Koning, Matthijs Oudkerk

    Resumen Resumen Esquema Esquema   
• • ·Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial

    Página :917-927

    Toni K Choueiri, Bernard Escudier, Thomas Powles, Nizar M Tannir, Paul N Mainwaring, Brian I Rini, Hans J Hammers, Frede Donskov, Bruce J Roth, Katriina Peltola, Jae Lyun Lee, Daniel Y C Heng, Manuela Schmidinger, Neeraj Agarwal, Cora N Sternberg, David F McDermott, Dana T Aftab, Colin Hessel, Christian Scheffold, Gisela Schwab, Thomas E Hutson, Sumanta Pal, Robert J Motzer, METEOR investigators

    Resumen Resumen Esquema Esquema   
• • ·First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

    Página :928-942

    Barbara Eichhorst, Anna-Maria Fink, Jasmin Bahlo, Raymonde Busch, Gabor Kovacs, Christian Maurer, Elisabeth Lange, Hubert Köppler, Michael Kiehl, Martin Sökler, Rudolf Schlag, Ursula Vehling-Kaiser, Georg Köchling, Christoph Plöger, Michael Gregor, Torben Plesner, Marek Trneny, Kirsten Fischer, Harmut Döhner, Michael Kneba, Clemens-Martin Wendtner, Wolfram Klapper, Karl-Anton Kreuzer, Stephan Stilgenbauer, Sebastian Böttcher, Michael Hallek, international group of investigators, German CLL Study Group (GCLLSG)

    Resumen Resumen Esquema Esquema   
• • ·Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial

    Página :943-955

    Jeffrey S Weber, Geoff Gibney, Ryan J Sullivan, Jeffrey A Sosman, Craig L Slingluff, Donald P Lawrence, Theodore F Logan, Lynn M Schuchter, Suresh Nair, Leslie Fecher, Elizabeth I Buchbinder, Elmer Berghorn, Mary Ruisi, George Kong, Joel Jiang, Christine Horak, F Stephen Hodi

    Resumen Resumen Esquema Esquema   
• • ·Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

    Página :956-965

    Tanguy Y Seiwert, Barbara Burtness, Ranee Mehra, Jared Weiss, Raanan Berger, Joseph Paul Eder, Karl Heath, Terrill McClanahan, Jared Lunceford, Christine Gause, Jonathan D Cheng, Laura Q Chow

    Resumen Resumen Esquema Esquema   
• • ·Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database

    Página :966-975

    Daniel P Nussbaum, Christel N Rushing, Whitney O Lane, Diana M Cardona, David G Kirsch, Bercedis L Peterson, Dan G Blazer

    Resumen Resumen Esquema Esquema   
• • ·Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

    Página :976-983

    Sarah B Goldberg, Scott N Gettinger, Amit Mahajan, Anne C Chiang, Roy S Herbst, Mario Sznol, Apostolos John Tsiouris, Justine Cohen, Alexander Vortmeyer, Lucia Jilaveanu, James Yu, Upendra Hegde, Stephanie Speaker, Matthew Madura, Amanda Ralabate, Angel Rivera, Elin Rowen, Heather Gerrish, Xiaopan Yao, Veronica Chiang, Harriet M Kluger

    Resumen Resumen Esquema Esquema  
• • ·Dabrafenib plus trametinib in patients with previously treated BRAF^V600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

    Página :984-993

    David Planchard, Benjamin Besse, Harry J M Groen, Pierre-Jean Souquet, Elisabeth Quoix, Christina S Baik, Fabrice Barlesi, Tae Min Kim, Julien Mazieres, Silvia Novello, James R Rigas, Allison Upalawanna, Anthony M D’Amelio, Pingkuan Zhang, Bijoyesh Mookerjee, Bruce E Johnson

    Resumen Resumen Esquema Esquema   
• • ·Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial

    Página :994-1003

    David Cella, Viktor Grünwald, Paul Nathan, Justin Doan, Homa Dastani, Fiona Taylor, Bryan Bennett, Michael DeRosa, Scott Berry, Kristine Broglio, Elmer Berghorn, Robert J Motzer

    Resumen Resumen Esquema Esquema   
• • ·SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis

    Página :1004-1018

    Tarek M A Abdel-Fatah, Devika Agarwal, Dong-Xu Liu, Roslin Russell, Oscar M Rueda, Karen Liu, Bing Xu, Paul M Moseley, Andrew R Green, Alan G Pockley, Robert C Rees, Carlos Caldas, Ian O Ellis, Graham R Ball, Stephen Y T Chan

    Resumen Resumen Esquema Esquema   
• • ·Prophylactic cranial irradiation for patients with lung cancer

    Página :e277

    Cécile Le Péchoux, Alexander Sun, Ben J Slotman, Dirk De Ruysscher, José Belderbos, Elizabeth M Gore

    Resumen Resumen Esquema Esquema  
• • ·Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials

    Página :e294

    Irina Ghislain, Efstathios Zikos, Corneel Coens, Chantal Quinten, Vasiliki Balta, Konstantinos Tryfonidis, Martine Piccart, Dimitrios Zardavas, Eva Nagele, Vesna Bjelic-Radisic, Fatima Cardoso, Mirjam A G Sprangers, Galina Velikova, Andrew Bottomley, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group, Breast Cancer Group, EORTC Headquarters

    Resumen Resumen Esquema Esquema   
• • ·Challenges in breast and cervical cancer control in Japan

    Página :e305

    Catherine Sauvaget, Yoshikazu Nishino, Ryo Konno, Toru Tase, Tadaoki Morimoto, Shigeru Hisamichi

    Resumen Resumen Esquema Esquema